Page 98 - TD-3-4

Tumor Discovery RNA-protein complexes deregulated in cancer

279. Qu M, He Q, Bao H, et al. The multiple roles of arsenic 289. Tong F, Hu H, Xu Y, et al. Hollow copper sulfide nanoparticles
compounds in phase separation and membraneless carrying ISRIB for the sensitized photothermal therapy
organelle formation determine their therapeutic efficacy in of breast cancer and brain metastases by inhibiting stress
tumors. J Pharm Anal. 2024;14(8):100957. granule formation and reprograming tumor-associated
macrophages. Acta Pharmacol Sin B. 2023;13:3471-3488.
doi: 10.1016/j.jpha.2024.02.011
doi: 10.1016/j.apsb.2022.11.003
280. Li X, Yu Z. Role of liquid-liquid phase separation in cancer:
Mechanisms and therapeutic implications. Cancer Innov. 290. Zyryanova AF, Kashiwagi K, Rato C, et al. ISRIB blunts the
2024;3(5):e144. integrated stress response by allosterically antagonizing the
inhibitory effect of phosphorylated eIF2 on eIF2b. Mol Cell.
doi: 10.1002/cai2.144
2021;81:88-103.e6.
281. Zhang W, Li Z, Wang X, Sun T. Phase separation doi: 10.1016/j.molcel.2020.10.03
is regulated by posttranslational modifications and
participates in the development of human diseases. Heliyon. 291. Hou WC, Massey LA, Rhoades D, et al. A PIKfyve modulator
2024;10(13):e34035. combined with an integrated stress response inhibitor to
treat lysosomal storage diseases. Proc Natl Acad Sci U S A.
doi: 10.1016/j.heliyon.2024.e34035 2024;121(34):e2320257121.
282. Liu Z, Qin Z, Liu Y, et al. Liquid-liquid phase separation: doi: 10.1073/pnas.2320257121
roles and implications in future cancer treatment. Int J Biol
Sci. 2023;19(13):4139-4156. 292. Cao X, Zhang Y, Ding Y, Wan Y. Identification of RNA
structures and their roles in RNA functions. Nat Rev Mol
doi: 10.7150/ijbs.81521 Cell Biol. 2024;25(10):784-801.
283. Balavaishnavi B, Kamaraj M, Nithya TG, Santhosh P, doi: 10.1038/s41580-024-00748-6
GokilaLakshmi S, Shaik MR. Regulation of hippo signaling-
mediated apoptosis by Rauvolfia tetraphylla in triple- 293. He C, Wu CY, Li W, Xu K. Multidimensional super-
negative breast cancer. Med Oncol. 2024;41(5):103. resolution microscopy unveils nanoscale surface aggregates
in the aging of FUS condensates. J Am Chem Soc.
doi: 10.1007/s12032-024-02341-5 2023;145(44):24240-24248.
284. Wang J, Hu L, Zhang H, Fang Y, Wang T, Wang H. doi: 10.1021/jacs.3c08674
Intracellular condensates of oligopeptides for targeting
lysosomes and addressing multiple drug resistance of cancer. 294. Choi AA, Xu K. Single-molecule diffusivity quantification
Adv Mater. 2022;34(1):e2104704. unveils ubiquitous net charge-driven protein-protein
interaction. J Am Chem Soc. 2024;146(15):10973-10978.
doi: 10.1002/adma.202104704
doi: 10.1021/jacs.4c02475
285. Grosch M, Ittermann S, Rusha E, et al. Nucleus size and
DNA accessibility are linked to the regulation of paraspeckle 295. Yao RW, Rosen MK. Advanced surface passivation for high-
formation in cellular differentiation. BMC Biol. 2020;18:42. sensitivity studies of biomolecular condensates. Proc Natl
Acad Sci U S A. 2024;121(22):e2403013121.
doi: 10.1186/s12915-020-00770-y
doi: 10.1101/2024.02.12.580000
286. Jia Y, Jia R, Dai Z, et al. Stress granules in cancer:
Adaptive dynamics and therapeutic implications. iScience. 296. Paul S, Mondal S, Shenogina I, Cui Q. The molecular
2024;27(8):110359. basis for the increased stability of the FUS-LC fibril at the
anionic membrane- and air-water interfaces. Chem Sci.
doi: 10.1016/j.isci.2024.110359 2024;15(34):13788-13799.
287. Dinh NTM, Nguyen TM, Park MK, Lee CH. Y-box binding doi: 10.1039/d4sc02295e
protein 1: Unraveling the multifaceted role in cancer
development and therapeutic potential. Int J Mol Sci. 297. Xia C, Colognori D, Jiang X, Xu K, Doudna JA. Single-
molecule live-cell RNA imaging with CRISPR-Csm. bioRxiv
2024;25(2):717.
[Preprint]. 2024:2024.07.14.603457.
doi: 10.3390/ijms25020717
doi: 10.1101/2024.07.14.603457
288. Shen X, Peng X, Guo Y, et al. YAP/TAZ enhances P-body 298. Guan A, Wong JJ. Targeting RNA modifications with
formation to promote tumorigenesis. Elife. 2024;12:RP88573.
pharmacological agents: New frontiers in cancer therapy.
doi: 10.7554/eLife.88573 Cancer Med. 2024;13(7):e6989.

Volume 3 Issue 4 (2024) 39 doi: 10.36922/td.4657